Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
Kidney cancer statistics
New cases of kidney cancer, 2015, UK
Deaths from kidney cancer, 2016, UK.
Survive kidney cancer for 10 or more years, 2010-11, England and Wales
Kidney cancer cases are preventable, UK, 2015
- There are around 12,600 new kidney cancer cases in the UK every year, that's 34 every day (2013-2015).
- Kidney cancer is the 7th most common cancer in the UK, accounting for 3% of all new cancer cases (2015).
- In males in the UK, kidney cancer is the 6th most common cancer, with around 7,900 new cases in 2015.
- In females in the UK, kidney cancer is the 10th most common cancer, with around 4,600 new cases in 2015.
- Incidence rates for kidney cancer in the UK are highest in people aged 85 to 89 (2013-2015).
- Since the early 1990s, kidney cancer incidence rates have increased by almost nine-tenths (85%) in the UK. Rates in males have increased by around three-quarters (76%), and rates in females have increased by around nine-tenths (91%).
- Over the last decade, kidney cancer incidence rates have increased by almost half (47%) in the UK. Rates in males have increased by more than two-fifths (44%), and rates in females have increased by almost half (47%).
- More than 4 in 10 kidney cancer cases are diagnosed at a late stage in England (2014) and Northern Ireland (2010-2014).
- Most kidney cancers occur in the kidney itself.
- Incidence rates for kidney cancer are projected to rise by 26% in the UK between 2014 and 2035, to 32 cases per 100,000 people by 2035.
- Kidney cancer in England is more common in people living in the most deprived areas.
- Kidney cancer is more common in White males than in Asian or Black males.
- Kidney cancer is more common in White females than in Black females, but similar to Asian females, but Asian and Black females are similar to each other.
- An estimated 46,800 people who had previously been diagnosed with kidney cancer were alive in the UK at the end of 2010.
- There are around 4,500 kidney cancer deaths in the UK every year, that's 12 every day (2014-2016).
- Kidney cancer is the 13th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2016).
- In males in the UK, kidney cancer is the 10th most common cause of cancer death, with around 2,900 deaths in 2016.
- In females in the UK, kidney cancer is the 14th most common cause of cancer death, with around 1,700 deaths in 2016.
- Mortality rates for kidney cancer in the UK are highest in people aged 90+ (2014-2016).
- Since the early 1970s, kidney cancer mortality rates have increased by around three-quarters (74%) in the UK. Rates in males have increased by almost three-quarters (73%), and rates in females have increased by around two-thirds (67%).
- Over the last decade, kidney cancer mortality rates have increased by a twentieth (5%) in the UK. Rates in males have remained stable, and rates in females have remained stable.
- Mortality rates for kidney cancer are projected to fall by 15% in the UK between 2014 and 2035, to 8 deaths per 100,000 people by 2035.
- Kidney cancer deaths in England are more common in people living in the most deprived areas.
- Half (50%) of people diagnosed with kidney cancer in England and Wales survive their disease for ten years or more (2010-11).
- Almost 6 in 10 (56%) people diagnosed with kidney cancer in England and Wales survive their disease for five years or more (2010-11).
- More than 7 in 10 (72%) people diagnosed with kidney cancer in England and Wales survive their disease for one year or more (2010-11).
- Kidney cancer survival is higher in men than women at one- and five-years but similar at ten-years.
- Kidney cancer survival in England is highest for people diagnosed aged under 50 years old (2009-2013).
- Around three-quarters of people in England diagnosed with Kidney cancer aged 15-49 survive their disease for five years or more, compared with more than a third of people diagnosed aged 80 and over (2009-2013).
- Kidney cancer survival is improving and has increased in the last 40 years in the UK.
- In the 1970s, almost a quarter of people diagnosed with kidney cancer survived their disease beyond ten years, now it's half.
- When diagnosed at its earliest stage, more than 8 in 10 people with kidney cancer will survive their disease for five years or more, compared with less than 1 in 10 people when at the latest stage.
- Five-year relative survival for kidney cancer in men and women is below the European average in England, Scotland, Wales and Northern Ireland.
- A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- 1 in 34 UK males and 1 in 61 UK females will be diagnosed with kidney cancer in their lifetime.
- 34% of kidney cancer cases in the UK are preventable.
- 13% of kidney cancer cases in the UK are caused by smoking.
- 24% of kidney cancer cases in the UK are caused by overweight and obesity.
- 'GP referral' is the most common route to diagnosing kidney cancer.
- GP referral is the route with the highest proportion of cases diagnosed at an early stage, for kidney cancer.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ and ‘62 day wait’ are not met by any country for urological cancers.
- 56% of patients diagnosed with kidney cancer have surgery to remove the tumour as part of their primary cancer treatment.
- 8% of patients diagnosed with kidney cancer have radiotherapy as part of their primary cancer treatment.
- 13% of patients diagnosed with kidney cancer have chemotherapy as part of their primary cancer treatment.
The latest statistics available for kidney cancer in the UK are; incidence 2015, mortality 2014 and survival 2010-2011 (all ages combined) and 2009-2013 (by age).
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Risk factor evidence is for renal cell carcinoma (RCC) unless otherwise specified.
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013. Staging proportions only include patients with a known stage (cases with an unknown stage at diagnosis are not included in the denominator).
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Kidney cancer is part of the group 'Urological cancer' for cancer waiting times data. Codes vary per country but broadly include: penis, prostate, testis, other and unspecified male genital organs, kidney, renal pelvis, ureter, bladder, other and unspecified urinary organs, secondary cancers of kidney, renal pelvis, bladder and other unspecified urinary organs.
Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.